12 - Vanda Pharmaceuticals FDA Update for HETLIOZ in the Treatment of Jet Lag Disorder
FDA-2022-N-2390-0610Supporting & Related Material
Document
Details
The document's own metadata, straight from the source system.
- Title
- 12 - Vanda Pharmaceuticals FDA Update for HETLIOZ in the Treatment of Jet Lag Disorder
- Posted
- May 20, 2026
- Topics